Search
Menu
Home
Sources
About
Contacts
Lecozotan
Lecozotan
is an
investigational drug
by
Wyeth
tested
for
improvement
of
cognitive functions
of
Alzheimer's disease
patients
.
, the first
Phase III clinical trial
has been
completed
.
Method
of
action
Lecozotan is a
competitive
,
selective
5-HT
1A
receptor antagonist
which enhances the potassium-stimulated
release
of
acetylcholine
and
glutamate
.
